Concepedia

Omar Duramad

OD

14

Publications

3.9K

Citations

14

H-Index

2000

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dynavax Technologies (United States)

Stanford University

University of California, Berkeley

Omar Duramad is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

2000–2017

14

Publications

14

TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand

Tomoki� Ito, Yui-Hsi Wang, Omar Duramad et al. · The Journal of Experimental Medicine · 2005 · 1.1K citations · Full text

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

Franck J. Barrat, Thea Meeker, Josh Gregorio et al. · The Journal of Experimental Medicine · 2005 · 915 citations · Full text

The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens

Yen-Michael S. Hsu, Yongliang Zhang, Yun You et al. · Nature Immunology · 2006 · 425 citations

, , +13

Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells

Tomoki� Ito, Holger Kanzler, Omar Duramad et al. · Blood · 2005 · 269 citations · Full text

ERK5 Is a Novel Type of Mitogen-Activated Protein Kinase Containing a Transcriptional Activation Domain

Herbert G. Kasler, Joseph Victoria, Omar Duramad et al. · Molecular and Cellular Biology · 2000 · 267 citations · Full text

, , +19

Rows per page

1–5 of 14